Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Gill Spyer"'
Autor:
Ali J. Chakera, Paul S. Hurst, Gill Spyer, Emmanuel O. Ogunnowo-Bada, William J. Marsh, Christine H. Riches, Chen-Yu Yueh, S. Pauliina Markkula, Jeffrey W. Dalley, Roger D. Cox, Ian A. Macdonald, Stephanie A. Amiel, Kenneth M. MacLeod, Lora K. Heisler, Andrew T. Hattersley, Mark L. Evans
Publikováno v:
Molecular Metabolism, Vol 17, Iss , Pp 17-27 (2018)
Objective: Appropriate glucose levels are essential for survival; thus, the detection and correction of low blood glucose is of paramount importance. Hypoglycemia prompts an integrated response involving reduction in insulin release and secretion of
Externí odkaz:
https://doaj.org/article/5aa2ee6354054a39a0a0b99baae7f83c
Autor:
Elizabeth Uchegbu, Sharon J. Ellender, Rahul Nayar, Rajiv Gandhi, Christian Hariman, Victor Oguntolu, Deborah Fitzsimmons, David Russell, Eleanor F. Harrison, Frances L. Game, Judith L. Jacobsen, Gerry Rayman, Haroon Siddique, Kilimangalam Narayanan, Jan Tind Sørensen, Hans Gottlieb, Diane Whitham, Theingi Aung, Deidre Maguire, Lise Tarnow, William Jeffcoate, Eskild Henneberg, Harvey Chant, Marie-France Kong, Magnus Löndahl, Sergiu-Bogdan Catrina, Anna Marie Nielsen, Donald Whitelaw, Morton Michelsen, Arthur Ogunko, Kim Christian Houlind, Ketan Dhatariya, Gill Spyer, Helene Holmer, Satyan Rajbhandari, Ryan D'Costa, Peter Rossing, Mollie Donohoe, Bo Nørregaard Jørgensen, Ammar Tarik
Publikováno v:
LeucoPatch II trial team & Houlind, K C 2018, ' LeucoPatch system for the management of hard-to-heal diabetic foot ulcers in the UK, Denmark, and Sweden : an observer-masked, randomised controlled trial ', The Lancet Diabetes & Endocrinology, vol. 6, no. 11, pp. 870-878 . https://doi.org/10.1016/S2213-8587(18)30240-7
BACKGROUND: The LeucoPatch device uses bedside centrifugation without additional reagents to generate a disc comprising autologous leucocytes, platelets, and fibrin, which is applied to the surface of the wound. We aimed to test the effectiveness of
Publikováno v:
Clinical Endocrinology. 60:711-718
objective Nonautoimmune hyperthyroidism (NAH), a rare autosomal dominantly inherited condition characterized by nonremitting thyrotoxicosis and the absence of features of autoimmune thyrotoxicosis, can result from activating germline mutations in the
OBJECTIVE Identifying glucokinase monogenic diabetes (GCK-MODY) in pregnancy is important, as management is different from management for other forms of gestational diabetes mellitus (GDM) and there is no increased maternal risk of type 2 diabetes. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3b41aa1c569a663ed20aee42f2a45f0
http://hdl.handle.net/10379/10735
http://hdl.handle.net/10379/10735
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association. 26(1)
To assess determinants of fetal growth in the offspring of pregnant women with hyperglycaemia due to a heterozygous glucokinase (GCK) gene mutation.Details of gestational age at delivery, fetal birth weight and maternal antenatal treatment were colle
Autor:
Beverley M. Shields, Bridget A. Knight, Sylvie Hauguel-de Mouzon, Gill Spyer, Andrew T. Hattersley, Penelope M. Clark, Sian Ellard, Annabelle S. Slingerland
Publikováno v:
Diabetes care. 31(4)
OBJECTIVE—In human pregnancy, placental weight is strongly associated with birth weight. It is uncertain whether there is regulation of the placenta by the fetus or vice versa. We aimed to test the hypothesis that placental growth is mediated, eith
Publikováno v:
Thyroid : official journal of the American Thyroid Association. 16(6)
The multiple endocrine neoplasia (MEN) type 2B is an autosomal dominant condition characterized by aggressive medullary C-cell tumors, pheochromocytoma, and a discrete physical appearance (marfanoid habitus, prominent corneal nerve fibers, thick lips
Publikováno v:
Lancet (London, England). 356(9246)
Summary Background Intensive treatment to achieve good glycaemic control in diabetic patients is limited by a high frequency of hypoglycaemia. The glucose concentrations at which symptoms and release of counter-regulatory hormones takes place have no
Publikováno v:
The Lancet. 355:1913
Publikováno v:
Thyroid; Jun2006, Vol. 16 Issue 6, p605-608, 4p